Ignite Creation Date:
2024-05-05 @ 10:12 PM
Last Modification Date:
2024-10-26 @ 10:15 AM
Study NCT ID:
NCT01058538
Status:
COMPLETED
Last Update Posted:
2014-02-25
First Post:
2010-01-27
Brief Title:
A Dose Finding Pharmacokinetic Study of the Tumour-targeting Human L19IL2 Monoclonal Antibody-Cytokine Fusion Protein in Patients With Advanced Solid Tumours
Sponsor:
Philogen SpA
Organization:
Philogen SpA
Organization Data
Organization:
Philogen SpA
Class:
INDUSTRY
Study ID:
PH-L19IL2-0105
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Philogen SpA
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Syneos Health | OTHER |